Edwards Lifesciences (EW) Long-Term Debt Repayments (2009 - 2022)

Edwards Lifesciences' Long-Term Debt Repayments history runs 12 years deep, the most recent figure standing at $100000.0 for Q4 2022.

• On a quarterly basis, Long-Term Debt Repayments changed 0.0% year-over-year to $100000.0 in Q4 2022; TTM through Dec 2022 was $200000.0, a 97.14% decrease from a year earlier, with the FY2023 full-year figure at $300000.0, up 50.0% from the prior year.
• Long-Term Debt Repayments steadied at $100000.0 in Q4 2022 per EW's latest filing, from $100000.0 in the prior quarter.
• Across five years, Long-Term Debt Repayments topped out at $601.2 million in Q4 2018 and bottomed at -$8.7 million in Q3 2021.
• The 5-year median for Long-Term Debt Repayments is $3.8 million (2019), against an average of $65.5 million.
• Across the five-year window, Long-Term Debt Repayments jumped 10635.71% in 2018 and sank 495.45% in 2021, its largest moves.
• Year by year, Long-Term Debt Repayments stood at $601.2 million in 2018, then sank by 99.14% to $5.2 million in 2019, then plunged by 42.31% to $3.0 million in 2020, then sank by 96.67% to $100000.0 in 2021, then changed by 0.0% to $100000.0 in 2022.
• Per Business Quant, the three latest EW Long-Term Debt Repayments figures stand at $100000.0 (Q4 2022), $100000.0 (Q2 2022), and $100000.0 (Q4 2021).